Variability in human metabolism of arsenic

Environmental Research

Volumn 92, Issue 2, 2003, Pages 85-91

  Loffredo, Christopher A ^a,e   Aposhian, H Vasken ^b   Cebrian, Mariano E ^c   Yamauchi, Hiroshi ^d   Silbergeld, Ellen K ^a,f  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Arizona   (United States)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f The Johns Hopkins University   (United States)

Author keywords

Arsenic; Cancer; Drinking water; Genetic polymorphisms; Methylation

Indexed keywords

ARSENIC; CACODYLIC ACID; INORGANIC COMPOUND; METHANEARSONIC ACID;

ARSENIC; CANCER; DRINKING WATER; HEALTH RISK; METABOLISM; POLLUTION EXPOSURE;

ARSENIC POISONING; ARTICLE; CHILE; CHINA; CONTROLLED STUDY; DATA ANALYSIS; ENVIRONMENTAL EXPOSURE; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENE FUNCTION; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; METAL METABOLISM; METHYLATION; MEXICO; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; URINALYSIS; URINE LEVEL; VARIANCE;

EID: 0038042653     PISSN: 00139351     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0013-9351(02)00081-6     Document Type: Article

References (39)

1. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Ann. Rev. Pharmacol. Toxicol. 37:1997;397-419.
2. Aposhian H.V., Arroyo A., Cebrian M.E., del Razo L.M., Hurlbut K.M., Dart R.C., Gonzalez-Ramirez D., Kreppel, H., Speisky H., Smith A., Gonsebatt M.E., Ostrosky-Wegman P., Aposhian M.M. DMPS-arsenic challenge test. I. Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate. J. Pharmacol. Exp. Ther. 282:1997;192-200.
3. Biggs M.L., Kalman D.A., Moore L.E., Hopenhayn-Rich C., Smith .M.T., Smith A.H. Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Mutat. Res. 386:1997;185-195.
4. Calderon R.L., Hudgens E., Le X.C., Schreinemachers D., Thomas D.J. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ. Health Perspect. 107:1999;663-667.
5. Cebrian M.E., Albores A., Aguilar M., Blakely E. Chronic arsenic poisoning in the north of Mexico. Hum. Toxicol. 2:1983;121-133.
6. Chen C.J., Chuang Y.C., Lin T.M., Wu H.Y. Malignant neoplasms among residents of a blackfoot disease endemic area in Taiwan. high arsenic artesian well water and cancers Cancer Res. 45:1985;5895-5899.
7. Chiou H.Y., Hseuh Y.M., Hsieh L.L., Hsu L.I., Hsu Y.H., Hsieh F.I., Wei M.L., Chen H.C., Yang H.T., Leu L.C., Chu T.H., Chen-Wu C., Yang M.H., Chen C.J. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat. Res. 386:1997;187-207.
8. Chung J.S., Kalman D.A., Moore L.F., Kosnett M.J., Arrayo A.P., Beeris M., Mazumder D.N., Hernandez A.L., Smith A.H. Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water. Environ. Health Perspect. 110:2002;729-733.
9. Del Razo L.M., Garcia-Vargas G.G., Vargas H., Albores A., Gonsebatt .M.E., Montero R., Ostrosky-Wegman P., Kelsh M., Cebrian M.E. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. Arch. Toxicol. 71:1997;211-217.
10. Goering P.L., Aposhian H.V., Mass M.J., Cedbrian M., Beck B.D., Wallkes M.P. The enigma of arsenic carcinogenesis. the role of metabolism Toxicol. Sci. 49:1999;5-14.
11. Gonsebatt M.E., Vega L., Salazar A.M., Montero R., Guzman P., Blas J., del Razo L.M., Garcia-Vargas G., Albores A., Cebrian M.E., Kelsh M., Ostrosky-Wegman P. Cytogenetic effects in human exposure to arsenic. Mutat. Res. 386:1997;219-228.
12. Hayes J.D., Pulford D.J. The glutathione-S-transferase supergene family. regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600.
13. Healy S.M., Casarez E.A., Ayala-Fierro F., Aposhian H.V. Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissue of mice. Toxicol. Appl. Pharmacol. 148:1998;65-70.
14. Hopenhayn-Rich C., Smith A.H., Goeden H.N. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res. 60:1993;161-177.
15. Hopenhayn-Rich C., Biggs M.L., Smith A.H., Kalman D.A., Moore L.E. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ. Health Perspect. 104:1996;620-628.
16. International Agency for Research on Cancer (IARC), 1980. IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: some metals and metallic compounds. World Health Organization, Lyon.
17. Jager J.W., Ostrosky-Wegman P. Arsenic. a paradoxical human carcinogen Mutat. Res. 386:1997;181-184.
18. Lim C.K. Kaiser M., Gabl F., Muler M.M., Bayer M. XI International Congress of Clinical Chemistry. 1982;957 de Gruyter, Berlin.
19. Lin S., Shi Q., Nix B., Styblo M., Beck M.A., Herbin-Davis K.M., Ball L.L., Simeonsson J.B., Thomas D.J. A novel s-adenosyl-L-methionine-arsenic (III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277:2002;10795-10803.
20. Marafante E., Vahter M., Norin H., Envall J., Sandstrom M., Christakopoulos A., Ryhage R. Biotransformation of dimethylarsinic acid in mouse, hamster, and man. J. Appl. Toxicol. 7:1987;111-117.
21. Mazumder D.N.G., Chakraborty A.K., Ghose A., Gupta J.D., Chakraborty D.P.et al. Chronic arsenic toxicity from drinking water in rural West Bengal. Bull. World Health Org. 66:1988;499-506.
22. Moore M.M., Harrington-Brick K., Doerr C.L. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 386:1997;279-290.
23. National Research Council (NRC), 1999. Arsenic in Drinking Water. National Academy Press, Washington, DC.
24. National Research Council (NRC), 2000. Arsenic in Drinking Water Update. NAS Press, Washington, DC.
25. Nelson H.H., Wiencke J.K., Christiani D.C., Cheng T.J., Zuo Z.-F., Schwartz B.S., Lee B.K., Spitz M.R., Wang M., Xu X., Kelsey K.T. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis. 16:1995;1243-1245.
26. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., Aposhian H.V. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163:2000;203-207.
27. Pi J., Kumagai Y., Sun G., Yamauchi H., Yoshida T., Iso H., Endo A., Yu L., Yuki K., Miyauchi T., Shimojo N. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radical Biol. Med. 28:2000;1137-1142.
28. Pott W.A., Benjamin S.A., Yang R.S. Pharmacokinetics, metabolism, and carcinogenicity of arsenic. Rev. Environ. Contam. Toxicol. 169:2001;165-214.
29. Queirolo F., Stepen S., Mondaca J., Cortes R., Rojas R., Contreras C., Munoz L., Schuger M.J., Ostapszuk P. Total arsenic, lead, cadmium, copper, and zinc in some salt rivers in the northern Andes of Antofagasta, Chile. Sci. Total Environ. 255:2000;85-95.
30. Smith A.H., Goycolea M., Haque R., Biggs M.L. Marked increase in bladder and lung cancer in a region of northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147:1998;660-669.
31. Smith A.H., Arroyo A.P., Mazumder D.N., Kosnett M.J., Hernandez A.L., Beeris M., Smith M.M., Moore L.E. Arsenic-induced skin lesions among Atacameno people in northern Chile despite good nutrition and centuries of exposure. Environ. Health. Perspect. 108:2000;617-620.
32. Thomas D.J., Styblo M., Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176:2001;127-144.
33. Thompson D.J. A chemical hypothesis for arsenic methylation in mammals. Chem. -Biol. Interact. 88:1993;89-114.
34. Thompson P.A., Shields P.G., Freudenheim J.L., Stone A., Vena J.E., Marshall J.R., Graham S., Laughlin R., Nemoto T., Kadlubar F.F., Ambrosone C.B. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res. 58:1998;2107-2110.
35. Tondel M., Rahman M., Magnuson A., Akhter Chowdhury I., Faruquee M.H., Ahmad Sk A. The relationship of arsenic levels in drinking water and the prevalence of skin lesions in Bangladesh. Environ. Health Perspect. 107:1993;727-729.
36. Vahter M. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett. 112:2000;209-217.
37. Vahter M., Concha G. Role of metabolism in arsenic toxicity. Pharmacol. Toxicol. 89:2001;1-5.
38. World Health Organization (WHO), 1983. Arsenic, Criteria Document for Health and the Environment 18, WHO, Geneva.
39. Yamamoto S., Arnold L.L., Ryder P., Uzvolgyi E., Cohen S.M. Cytotoxicity and mutagenicity of arsenicals on rat and human urothelial cells. Toxicol. Sci. 54:2000;133.